Share
305 Posts.
lightbulb Created with Sketch. 94
clock Created with Sketch. 08/11/24
16:51
Share
Originally posted by Steini:
↑
You don't need to list the above, I am fully aware of that. So are the ones who got the funds. And they aren't interested at all. Not one wants it for free. They could buy a big stake for a few millions, just to secure their share in case it turns out to be a hit. But nobody is interested. Hopper had lined up one or more in May and it collapsed. No one else jumped in - that is the truth. Follow the science as $$$ follow the science. neither at IMU nor CHM the $$$ are following the science. You can have the best treatment in the world, if nobody wants it, you are screwed. Of course it may change, but how likely is it? IMU misjudged the market with the B-cell platform. It works well, even better than Herceptin and Keytruda and yet, no partner or buyer - shelfed. Now look at CHM 1101. Where are the offers? Deprioritized due to lack of funds. Great results but no interest. That's the fact and that shouldn't be ignored when it comes to financial investments.
Expand
you are making blanket statements that no one is interested.
(20min delay)